122 related articles for article (PubMed ID: 28984791)
1. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
[TBL] [Abstract][Full Text] [Related]
2. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
[TBL] [Abstract][Full Text] [Related]
4. [The long coding RNA GSTM3TV2 acts an oncogene to promote chemoresistance in pancreatic cancer].
Xiong GB; Yang G; Feng MY; Zhao FY; Zheng LF; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):691-697. PubMed ID: 31474062
[No Abstract] [Full Text] [Related]
5. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
7. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
[TBL] [Abstract][Full Text] [Related]
8. α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma.
Liang C; Fukuda T; Isaji T; Duan C; Song W; Wang Y; Gu J
Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129870. PubMed ID: 33571582
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
10. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer.
Lerbs T; Bisht S; Schölch S; Pecqueux M; Kristiansen G; Schneider M; Hofmann BT; Welsch T; Reissfelder C; Rahbari NN; Fritzmann J; Brossart P; Weitz J; Feldmann G; Kahlert C
BMC Cancer; 2017 Apr; 17(1):249. PubMed ID: 28388884
[TBL] [Abstract][Full Text] [Related]
12. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
[TBL] [Abstract][Full Text] [Related]
13. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
14. Expression and Therapeutic Potential of SOX9 in Chordoma.
Chen H; Garbutt CC; Spentzos D; Choy E; Hornicek FJ; Duan Z
Clin Cancer Res; 2017 Sep; 23(17):5176-5186. PubMed ID: 28606919
[No Abstract] [Full Text] [Related]
15. LncRNA THOR increases the stemness of gastric cancer cells via enhancing SOX9 mRNA stability.
Song H; Xu Y; Shi L; Xu T; Fan R; Cao M; Xu W; Song J
Biomed Pharmacother; 2018 Dec; 108():338-346. PubMed ID: 30227327
[TBL] [Abstract][Full Text] [Related]
16. SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2.
Masuo K; Chen R; Yogo A; Sugiyama A; Fukuda A; Masui T; Uemoto S; Seno H; Takaishi S
Cancer Sci; 2021 Dec; 112(12):4987-4999. PubMed ID: 34628696
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9.
Li J; Wang L; Liu Z; Zu C; Xing F; Yang P; Yang Y; Dang X; Wang K
Oncotarget; 2015 Sep; 6(28):26216-29. PubMed ID: 26317788
[TBL] [Abstract][Full Text] [Related]
18. Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells.
Yin T; Wei H; Leng Z; Yang Z; Gou S; Wu H; Zhao G; Hu X; Wang C
Chemotherapy; 2011; 57(6):488-96. PubMed ID: 22248802
[TBL] [Abstract][Full Text] [Related]
19. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
[TBL] [Abstract][Full Text] [Related]
20. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.
Zhao G; Cui J; Zhang JG; Qin Q; Chen Q; Yin T; Deng SC; Liu Y; Liu L; Wang B; Tian K; Wang GB; Wang CY
Gene Ther; 2011 Sep; 18(9):920-8. PubMed ID: 21677689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]